Alpha Cognition Inc.
ACOG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001655923
In the last 90 days, Alpha Cognition Inc. insiders filed 6 open-market purchases and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $75.7M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Alpha Cognition Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 22 | 26 | +4 |
| Shares | 6.34M | 5.72M | −619.4K (−9.8%) |
| Value | $32.4M | $53.4M | +$20.9M (+64.5%) |
New holders (9)
Institutions that held Alpha Cognition Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 64,325 | $600.2K | 0.00% |
| UBS Group AG | 31,899 | $297.6K | 0.00% |
| Millennium Management LLC | 17,224 | $160.7K | 0.00% |
| Wexford Capital LP | 16,666 | $155.5K | 0.04% |
| Massar Capital Management, LP | 12,433 | $116.0K | 0.09% |
| Geode Capital Management, LLC | 11,992 | $111.9K | 0.00% |
| Berkshire Asset Management LLC | 11,824 | $110.3K | 0.01% |
| BlackRock, Inc. | 5,443 | $50.8K | 0.00% |
| Morgan Stanley | 525 | $4.90K | 0.00% |
Sold out (5)
Institutions that held Alpha Cognition Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Alyeska Investment Group, L.P. | 337,466 | $1.71M |
| Altium Capital Management LP | 177,416 | $897.7K |
| Rosalind Advisors, Inc. | 104,836 | $530.5K |
| MYDA Advisors LLC | 46,000 | $232.8K |
| Hohimer Wealth Management, LLC | 41,608 | $210.5K |